Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia. (2016). Mediterranean Journal of Hematology and Infectious Diseases, 8, e2016016. https://doi.org/10.4084/mjhid.2016.016